The Effect of Escitalopram on the Level of Inflammatory Factors and Endothelial Function in Patients with Coronary Heart Disease Accompanied by Anxiety and Depression
WANG Wenfeng, DING Shoukun
The People's Hospital of Dancheng County, Zhoukou Henan 477150
Abstract：【Objective】To investigate the effect of escitalopram on the levels of inflammatory factors and vascular endothelial function in patients with coronary heart disease accompanied by anxiety and depression. 【Methods】A total of 112 patients with coronary heart disease accompanied by anxiety and depression admitted to two hospitals from July 2021 to July 2022 were selected and randomly divided into an observation group and a control group according to a random number table method, with 56 cases in each group. The control group was given conventional drug treatment, while the observation group was treated with escitalopram on the basis of the control group. The vascular endothelial function [endothelin-1(ET-1), vascular endothelial growth factor(VEGF), nitric oxide(NO)], inflammatory factors [interleukin-2(IL-2), C-reactive protein(CRP), interleukin-8(IL-8), tumor necrosis factor-α(TNF-α)], neurotransmitters [brain-derived neurotrophic factor(BDNF), norepinephrine(NE), serotonin(5-HT)], cognitive function [Loewenstein Cognitive Assessment Rating Scale(LOTCA) score], Hamilton Depression Rating Scale(HAMD) score, and Hamilton Anxiety Rating Scale(HAMA) score were compared before and after treatment between the two groups. 【Results】After treatment, the levels of ET-1, TNF-α, IL-8, CRP, and IL-2 in the observation group were lower than those in the control group, while NO and VEGF were higher than those in the control group(P<0.05). After treatment, the levels of BDNF, NE, and 5-HT in the observation group were higher than those in the control group(P<0.05). After treatment, the LOTCA scores and total scores in the observation group were higher than those in the control group(P<0.05). After treatment, the HAMD and HAMA scores in the observation group were lower than those in the control group(P<0.05). 【Conclusion】Escitalopram has significant effect on improving negative emotions in patients with coronary heart disease accompanied by anxiety and depression, which can reduce the inflammatory response and improve vascular endothelial function.
王文锋, 丁守坤. 艾司西酞普兰对冠心病伴焦虑、抑郁患者炎症因子水平及血管内皮功能的影响[J]. 医学临床研究, 2024, 41(3): 424-426.
WANG Wenfeng, DING Shoukun. The Effect of Escitalopram on the Level of Inflammatory Factors and Endothelial Function in Patients with Coronary Heart Disease Accompanied by Anxiety and Depression. JOURNAL OF CLINICAL RESEARCH, 2024, 41(3): 424-426.
2024, Vol. 41 
